EBITDA — year on yearDKK millionsKey figuresAnnual report 2024
Revenue
DKK -1,2M
-75%
EBITDA
DKK -1,8M
+70%
Net profit
DKK -1,9M
+65%
Total assets
DKK 1,9M
-44%
Equity
DKK -9,1M
-26%
Employees
1
—
Company information
Legal name
MyoPax Denmark ApS
CVR number
43078046
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22. februar 2022
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er udvikling, produktion og distribution af lægemidler til behandling af muskeldefekter og generaliseret muskelsvind, herunder genetiske muskelsygdomme.
Contact
Address
Ole Maaløes Vej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.